The General Anesthesia Drugs Market is anticipated to reach a value of US$ 4.7 billion by the end of 2022 and to grow at a CAGR of 3.4% to US$ 6.7 billion by 2032. In 2021, the propofol medication class will dominate the global market, with a share of around 25.6%, according to a recent analysis by Future Market Insights.
The General Anesthesia Drugs Market is expected to be adversely...